Geode Capital Management, LLC Navidea Biopharmaceuticals, Inc. Transaction History

Geode Capital Management, LLC

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2023 Nov 13, 2023	BUY	$0.07 - $0.12 $18,748 - $32,139	267,832 Added 265.19%	368,830 $33,000
Q2 2023 Aug 11, 2023	SELL	$0.08 - $0.29 $289 - $1,050	-3,621 Reduced 3.46%	100,998 $9,000
Q2 2022 Aug 12, 2022	BUY	$0.63 - $1.1 $4,670 - $8,154	7,413 Added 7.63%	104,619 $75,000
Q2 2021 Aug 13, 2021	BUY	$1.55 - $2.15 $34,199 - $47,437	22,064 Added 29.36%	97,206 $177,000
Q3 2020 Nov 13, 2020	BUY	$2.69 - $4.95 $97,278 - $179,006	36,163 Added 92.78%	75,142 $202,000
Q2 2020 Aug 13, 2020	BUY	$0.7 - $4.16 $2,079 - $12,355	2,970 Added 8.25%	38,979 $153,000
Q2 2019 Aug 14, 2019	BUY	$0.62 - $3.6 $22,325 - $129,632	36,009 New	36,009 $22,000

10.4K

Ticker NAVB
Exchange NYSE
Sector Healthcare
Industry Biotechnology
Shares Outstandng 32,150,900
Description
Navidea Biopharmaceuticals, Inc., a biopharmaceutical company, focuses on the development and commercialization of precision immunodiagnostic agents and immunotherapeutics. It operates through two segments, Diagnostic Substances and Therapeutic Development Programs. The company develops Manocept platform to target the CD206 mannose receptor expr...

Get notified when there are updates to the investment portfolio of Geode Capital Management, LLC, based on Form 13F filings with the SEC.

Stay updated on Geode Capital Management, LLC with notifications on news.